RecruitingNot ApplicableNCT07322445

Multi-modal Imaging of Myofascial Pain - Phase 2

Development and Identification of Magnetic Resonance, Electrophysiological, and Fiber-optic Imaging Biomarkers of Myofascial Pain

Sponsor

Washington University School of Medicine

Enrollment

100 participants

Start Date

Oct 1, 2025

Study Type

INTERVENTIONAL

Conditions

myofascial pain

Summary

The goal of this study is to evaluate imaging biomarkers for quantitative assessments of myofascial pain and determine their ability to monitor treatment response and predict clinical outcomes.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called 50/50 Mixture of Lidocaine 1% injection + Bupivacaine 0.25% Injectable Solution and a procedure called Dry Needling for people with myofascial pain. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUG50/50 Mixture of Lidocaine 1% injection + Bupivacaine 0.25% Injectable Solution

Treatment Group: Receives trigger-point injection with a 50/50 mixture of 1% lidocaine and 0.25% bupivacaine

PROCEDUREDry Needling

Single session of dry needling to the identified trigger point(s) per protocol.

Locations(1)

Washington University

St Louis, Missouri, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07322445

Related Trials

Magnetic Resonance Elastography to Monitor Response to Manual Therapy in Myofascial Pain

NCT072785702 locations